NCT02424773View on ClinicalTrials.gov

Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

April 30, 2015

Conditions
Acute Respiratory FailureImmunocompromised HostHigh Flow Oxygen Cannula
Interventions
DEVICE

High Flow Nasal Canula (HFNC)

DEVICE

Venturi mask

DRUG

Oxygen

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02424773 - Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients | Biotech Hunter | Biotech Hunter